E-LIB Suche - Ergebnisse für: Van Deun, Armand

1

Safety of high-dose amikacin in the first week of all-oral ..:

Snobre, Jihad ; Gasana, Joel ; Ngabonziza, Jean Claude Semuto...
BMJ Open. 14 (2024) 7 - p. e078379 , 2024

Link: https://doi.org/10.1136/..

2

Borderline rpoB mutations transmit at the same rate as comm..:

Lempens, Pauline ; Van Deun, Armand ; Aung, Kya J. M....
Microbial Genomics. 9 (2023) 9 - p. , 2023

Link: https://doi.org/10.1099/..

3

High rate of adverse drug reactions with a novel tuberculos..:

Souleymane, Mahamadou Bassirou ; Kadri, Sani ; Piubello, Alberto...
International Journal of Infectious Diseases. 133 (2023) - p. 78-81 , 2023

Link: https://doi.org/10.1016/..

4

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB..:

Rigouts, Leen ; Keysers, Jelle ; Rabab, Reenaers...
BMC Research Notes. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Evaluation of two short standardised regimens for the treat..:

Goodall, Ruth L ; Meredith, Sarah K ; Nunn, Andrew J...
The Lancet. 400 (2022) 10366 - p. 1858-1868 , 2022

Link: https://doi.org/10.1016/..

6

Pretomanid for tuberculosis: a systematic review:

Gils, Tinne ; Lynen, Lutgarde ; de Jong, Bouke C...
Clinical Microbiology and Infection. 28 (2022) 1 - p. 31-42 , 2022

Link: https://doi.org/10.1016/..

7

Acquired rifampicin resistance during first TB treatment: m..:

Van Deun, Armand ; Bola, Valentin ; Lebeke, Rossin...
JAC-Antimicrobial Resistance. 4 (2022) 2 - p. , 2022

Link: https://doi.org/10.1093/..

8

Safety, effectiveness, and adherence of a short and all-ora..:

Souleymane, Mahamadou Bassirou ; Decroo, Tom ; Soumana, Alphazazi...
Trials. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

9

Definitive outcomes in patients with rifampicin-resistant t..:

Souleymane, Mahamadou Bassirou ; Decroo, Tom ; Mamadou, Saïdou...
International Health. 15 (2022) 3 - p. 258-264 , 2022

Link: https://doi.org/10.1093/..

10

Implications of bedaquiline-resistant tuberculosis:

Decroo, Tom ; van Deun, Armand
The Lancet Infectious Diseases. 22 (2022) 2 - p. 166-167 , 2022

Link: https://doi.org/10.1016/..

11

Keeping up with the guidelines: design changes to the STREA..:

Goodall, Ruth L. ; Sanders, Karen ; Bronson, Gay...
Trials. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

Acquired bedaquiline resistance during the treatment of dru..:

Mallick, Jahan Saeed ; Nair, Parvati ; Abbew, Elizabeth Tabitha..
JAC-Antimicrobial Resistance. 4 (2022) 2 - p. , 2022

Link: https://doi.org/10.1093/..

13

Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald..:

Ngabonziza, Jean Claude S ; Decroo, Tom ; Maniliho, Rodrigue...
Open Forum Infectious Diseases. 8 (2021) 2 - p. , 2021

Link: https://doi.org/10.1093/..

14

Bedaquiline can act as core drug in a standardised treatmen..:

Decroo, Tom ; Aung, Kya Jai Maug ; Hossain, Mohamed Anwar...
European Respiratory Journal. 59 (2021) 3 - p. 2102124 , 2021

Link: https://doi.org/10.1183/..

15

Should treatment of low-level rifampicin mono-resistant tub..:

Van Deun, Armand ; Decroo, Tom
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 23 (2021) - p. 100240 , 2021

Link: https://doi.org/10.1016/..